Thrombosomes® in Acute Thoracic Aortic Dissections

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

April 11, 2024

Study Completion Date

April 11, 2024

Conditions
Thoracic Aortic Dissection
Interventions
BIOLOGICAL

Thrombosomes®

The intervention with TBX® is to be administered as an intravenous infusion as hemostatic blood product as part of the Massive Transfusion Protocol (MTP).

BIOLOGICAL

Standard platelet concentrate

The administration of standard platelets is administrated, as part of the Massive Transfusion Protocol (MTP).

Trial Locations (1)

Unknown

Rigshospitalet, Copenhagen University Hospital, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Cellphire Therapeutics, Inc.

INDUSTRY

lead

Jakob Stensballe, MD, PhD

OTHER